Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
April 23, 2024 16:15 ET
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., April 23, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving...
Aspen Ideas: Health Announces Global Health Experts to Speak at Annual Summit
April 23, 2024 09:56 ET
|
The Aspen Institute
Aspen, CO & Washington, DC, April 23, 2024 (GLOBE NEWSWIRE) -- On Friday, the organizers of the Aspen Institute’s annual health summit, Aspen Ideas: Health, announced additional speakers joining...
Dalrada Financial Corporation’s Wholly-Owned Subsidiary, Genefic, Inc. Announces New Telemedicine Services, Enters Booming Weight Loss Drug Market
April 23, 2024 08:00 ET
|
Dalrada Financial Corp.
OTCQB: DFCO subsidiary announces entry into the global weight loss drug market currently worth approximately $6 billion
Western Europe Consumer Health Market: UK Adds the Most New Sales, Boosted by Self-Medication and Rx-to-OTC Switches
April 23, 2024 04:28 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Consumer Health in Western Europe" report has been added to ResearchAndMarkets.com's offering. While coughs, colds and the flu were less prevalent...
Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
April 18, 2024 16:05 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD)...
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global) 2024
April 18, 2024 07:30 ET
|
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and
Investigator-Initiated Pre-Clinical Studies at ESCMID Global (Formerly ECCMID)
Astaxanthin Market size worth $ 92.81 Billion, Globally, by 2031 at 2.38% CAGR – Report By Verified Market Research®
April 16, 2024 10:15 ET
|
Verified Market Research
Jersey City, New Jersey, April 16, 2024 (GLOBE NEWSWIRE) -- The Global Astaxanthin Market is projected to grow at a CAGR of 2.38% from 2024 to 2031, according to a new report published by Verified...
Asia Pharmaceutical Directory 2024: Top Source of Information on 10,000 Pharmaceutical and Biotechnology Companies
April 15, 2024 11:19 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Asian Pharmaceutical Directory 2024" directory has been added to ResearchAndMarkets.com's offering.Keep up-to-date with the Asian Pharmaceutical...
Global Pharma Handbook 2024: Expanded Coverage of Health Systems, Sales, Demand Profiles, Clinical Trials, Drug Approval Procedures, Regulatory Policies, IP, Pricing, Marketing, Generics
April 15, 2024 09:06 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Global Pharma Handbook 2024" directory has been added to ResearchAndMarkets.com's offering.The Global Pharma Handbook includes expanded coverage of...
European and USA Pharmaceutical Directory 2024: Indispensable Guide for Key Decision-makers
April 15, 2024 09:04 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "European and USA Pharmaceutical Directory 2024" directory has been added to ResearchAndMarkets.com's offering.The European & USA Pharmaceutical...